MedTrace Logo

Coagulation Parameters in IBD Patients

NCT04115722 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-10-04

No results posted yet for this study

Summary

1. to assess the incidence of coagulation disorders in IBD patients in comparison with another normal controlled group
2. risk factors that contribute to development of thrombosis in IBD patients
3. to determine the effectiveness of prophlactive anticoagulant measures
4. to determine the association between disease activity and coagulation parameters

Conditions

  • Coagulopathy

Interventions

OTHER

IBD ACTIVIT

Effect of IBD disease and activity of disease on coagulation parameters

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2020-11-30
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04115722 on ClinicalTrials.gov